Human Prion Protein Dimer: Difference between revisions
No edit summary |
No edit summary |
||
Line 29: | Line 29: | ||
[[Image:F4.large.jpg| | [[Image:F4.large.jpg|left|300px|thumb|Electrostatic potential alteration E200K|Caption: This shows (a&c) the electrostatic potential of wild-type Human Prion Protein with Glu200 and (b&d) the electrostatic potential of variant Lys200. <ref name="Zhang">PMID:10954699</ref>]] | ||
=== PrP<sup>Sc</sup> === | === PrP<sup>Sc</sup> === | ||
Line 54: | Line 43: | ||
The Cystine residues which were formerly part of disulfide bonds have been reduced catalytically without any chemical reducing agent. <ref name="Knaus">PMID:11524679</ref> | The Cystine residues which were formerly part of disulfide bonds have been reduced catalytically without any chemical reducing agent. <ref name="Knaus">PMID:11524679</ref> | ||
===Dimer Form=== | ===Dimer Form=== |